Regional spread and control of vancomycin-resistant and in Kyoto, Japan

被引:27
作者
Matsushima, A. [1 ,2 ]
Takakura, S. [1 ,2 ]
Yamamoto, M. [1 ,2 ]
Matsumura, Y. [1 ,2 ]
Shirano, M. [1 ,2 ]
Nagao, M. [1 ,2 ]
Ito, Y. [3 ]
Iinuma, Y. [4 ]
Shimizu, T. [5 ]
Fujita, N. [6 ]
Ichiyama, S. [1 ,2 ]
机构
[1] Kyoto Univ Hosp, Dept Infect Control & Prevent, Sakyo Ku, Kyoto 6068507, Japan
[2] Kyoto Univ, Dept Clin Lab Med, Grad Sch Med, Sakyo Ku, Kyoto 6068507, Japan
[3] Kyoto Univ, Dept Resp Med, Grad Sch Med, Sakyo Ku, Kyoto 6068507, Japan
[4] Kanazawa Med Univ, Dept Infect Dis, Uchinada, Ishikawa 9200293, Japan
[5] Kyoto City Hosp, Dept Infect Dis, Nakagyo Ku, Kyoto 6048845, Japan
[6] Kyoto Prefectural Univ Med, Dept Infect Control & Lab Med, Kamigyo Ku, Kyoto 6028566, Japan
关键词
FIELD GEL-ELECTROPHORESIS; SEQUENCE TYPING SCHEME; ENTEROCOCCUS-FAECIUM; COMPLEXES; SETTINGS; OUTCOMES; HEALTH; BROTH;
D O I
10.1007/s10096-011-1412-x
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The purpose of this investigation was to control the post-outbreak prevalence of vancomycin-resistant enterococci (VRE) in the affected Kyoto region. The study period was from 2005 to 2010. Faecal samples were subjected to VRE screening, and vancomycin resistance genes were detected by polymerase chain reaction (PCR). The genotype was determined by pulsed-field gel electrophoresis (PFGE) of genomic DNA digested with I and by multilocus sequence typing (MLST). A VRE control programme was established in 2006, consisting of a laboratory-based faecal VRE screening system, annual surveillance of hospital inpatients and the promotion of adequate infection control measures. -, - and - were detected at 35, 12 and 5 hospitals, respectively. Genotype analysis revealed that all of the vancomycin-resistant isolates obtained since 2005 belonged to ST78, and that clonally related - of ST64 had spread to three hospitals. The rate of faecal VRE carriage among the patients enrolled in the annual surveillance increased until 2007, when it reached 24 (1.2%) of the 2,035 enrolled patients. The rate began to decrease in 2008 and, by 2010, reached a low of 4 (0.17%) of the 2,408 enrolled patients. While VRE did spread within the Kyoto region, the VRE control programme succeeded in controlling the overall VRE spread.
引用
收藏
页码:1095 / 1100
页数:6
相关论文
共 50 条
  • [31] Controlling for endogeneity in attributable costs of vancomycin-resistant enterococci from a Canadian hospital
    Lloyd-Smith, Patrick
    [J]. AMERICAN JOURNAL OF INFECTION CONTROL, 2017, 45 (12) : E161 - E164
  • [32] Economic burden of nosocomial infections caused by vancomycin-resistant enterococci
    Puchter, Laura
    Chaberny, Iris Freya
    Schwab, Frank
    Vonberg, Ralf-Peter
    Bange, Franz-Christoph
    Ebadi, Ella
    [J]. ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL, 2018, 7
  • [33] Novel Vancomycin-Resistance Transposon, Plasmid Replicon Types, and Virulence Factors of Vancomycin-Resistant Enterococci in Zhejiang, China
    Qu, Ting-Ting
    Yang, Qing
    Shen, Ping
    Wei, Ze-Qing
    Yu, Yun-Song
    [J]. MICROBIAL DRUG RESISTANCE, 2012, 18 (02) : 183 - 188
  • [34] Emergency of vancomycin-resistant Enterococcus infections in a teaching hospital in Chile
    Fica C, Alberto
    Jemenao P., Maria Irene
    Bilbao V., Paola
    Ruiz R., Gloria
    Sakurada Z., Andrea
    Perez de Arce O., Edith
    Zuniga B., Isabel
    Gompertz G., Macarena
    [J]. REVISTA CHILENA DE INFECTOLOGIA, 2007, 24 (06): : 462 - 471
  • [35] American crows as carriers of vancomycin-resistant enterococci with vanA gene
    Oravcova, Veronika
    Zurek, Ludek
    Townsend, Andrea
    Clark, Anne B.
    Ellis, Julie C.
    Cizek, Alois
    Literak, Ivan
    [J]. ENVIRONMENTAL MICROBIOLOGY, 2014, 16 (04) : 939 - 949
  • [36] Effectiveness of patient and staff cohorting to reduce the risk of vancomycin-resistant enterococcus (VRE) acquisition: a retrospective cohort study during a VRE outbreak in Japan
    Kakimoto, K.
    Nishiki, S.
    Kaga, Y.
    Harada, T.
    Kawahara, R.
    Takahashi, H.
    Ueda, E.
    Koshimo, N.
    Lto, H.
    Matsui, T.
    Oishi, K.
    Yamagishi, T.
    [J]. JOURNAL OF HOSPITAL INFECTION, 2023, 134 : 35 - 42
  • [37] Emergence of vancomycin-resistant Enterococcus bloodstream infections in southern Taiwan
    Chou, Chien-Hsuan
    Lee, Nan-Yao
    Lee, Hsin-Chun
    Chang, Chia-Ming
    Lee, Ching-Chi
    Ko, Wen-Chien
    [J]. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2012, 45 (03) : 221 - 227
  • [38] Vancomycin-resistant enterococcal bacteraemia and daptomycin: are higher doses necessary?
    King, Esther A.
    McCoy, Dorothy
    Desai, Samit
    Nyirenda, Themba
    Bicking, Keri
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2011, 66 (09) : 2112 - 2118
  • [39] Risk factors for vancomycin-resistant Enterococcus colonization in hematologic patients
    Mioljevic, Vesna
    Markovic-Denic, Ljiljana
    Vidovic, Ana
    Jovanovic, Milica
    Tosic, Tanja
    Tomin, Dragica
    [J]. VOJNOSANITETSKI PREGLED, 2013, 70 (12) : 1109 - 1116
  • [40] What Is the Best Treatment for Vancomycin-Resistant Enterococcal Bloodstream Infections?
    Kanjilal, Sanjat
    Kalil, Andre C.
    Klompas, Michael
    [J]. CRITICAL CARE MEDICINE, 2018, 46 (10) : 1700 - 1703